[1] 李晨. 家族性扩张型心肌病临床特点、病因及治疗研究进展[J].中国伤残医学,2016,24(2):191-192. [2] 李天文. 辛伐他汀治疗扩张性心肌病心力衰竭的初步观察[J].当代医学,2009,15(3):9-10. [3] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.心血管疾病防治指南与共识[J].中华心血管病杂志,2007,35(1):5-16. [4] MCNALLY E M, GOLBUS J R, PUCKELWARTZ M J.Genetic mutations and mechanisms in dilated cardiomyopathy[J]. J Clin Invest, 2013, 123(1):19-26. [5] 李志芳,段成城,董丽妍.扩张型心肌病外周血炎性因子水平及其临床意义[J].检验医学与临床,2013,13(1):88-90. [6] HOFMANN U, FRANTZ S.How can we cure a heart ‘‘in flame''? A translational view on inflammation in heart failure[J]. Basic Res Cardiol, 2013, 108(4): 356-379. [7] CAIN B S, MELDRUM D R, DINARELLO C A, et al.Tumor necrosis factor-alpha and interleukin-1 beta synergistically depress human myocardial function[J]. 1999, 27(7): 1309-1318. [8] HO L J, LUO S F, LAI J H.Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers[J]. Biochem Pharmacol, 2015, 97(1): 16-26. [9] 段佳佳,夏大胜.慢性心力衰竭患者炎性细胞因子的变化及作用[J].中国心血管杂志,2012,17(2):93-95. [10] 叶小彬. 瑞舒伐他汀钙对急性冠脉综合征患者血清炎症因子及内皮功能的影响[J].中国老年学杂志,2017,37(17):4245-4247. |